English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The field of hepatic oncology is rapidly changing due to the availability of a large diagnostic and therapeutic armamentarium. The popularization of several loco-regional treatments LRT) and the recent introduction in clinical practice of drugs such as tyrokinase inhibitors have changed the therapeutic algorithm of hepatocellular cancer (HCC). The role of surgery has been reduced markedly [1, 2].This editorial aims at reminding surgical as well as medical communities that cure of liver cancer can only be obtained when resecting the tumor appropriately and that (long-term) results can be further improved when adhering to the classical oncologic paradigms

The modernized treatment of hepatocellular cancer: time to think twice!